hexamethylene bisacetamide and glycolipids

hexamethylene bisacetamide has been researched along with glycolipids in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, PW; Fenderson, BA; Hakomori, S; Nudelman, E1
Gubler, ML; Maffei, L; McCue, PA; Sherman, MI1

Other Studies

2 other study(ies) available for hexamethylene bisacetamide and glycolipids

ArticleYear
Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR).
    Differentiation; research in biological diversity, 1990, Volume: 43, Issue:2

    Topics: Acetamides; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Antigens, Surface; Biomarkers, Tumor; Bromodeoxyuridine; Cell Membrane; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Glycolipids; Humans; Membrane Lipids; Retinoids; Teratoma; Tumor Cells, Cultured

1990
Complementation analyses of differentiation-defective embryonal carcinoma cells.
    Developmental biology, 1984, Volume: 103, Issue:2

    Topics: Acetamides; Animals; Antigens, Surface; Carrier Proteins; Cell Differentiation; Cell Line; Embryonal Carcinoma Stem Cells; Glycolipids; Hybrid Cells; Lewis X Antigen; Male; Mice; Mutation; Neoplastic Stem Cells; Plasminogen Activators; Receptors, Retinoic Acid; Stem Cells; Teratoma; Tretinoin

1984